PubMed · 221310
Decrease in serum receptor-reactive somatomedin in diabetes.
Abstract
Somatomedin in rat serum has been measured by a sensitive radioreceptor assay using 125I-labelled human somatomedin and human placental membrane. In rats made diabetic with strepotzotocin, receptor-reactive somatomedin levels were decrease by up to 75%. The decrease followed the time course of increasing serum glucose and occurred to the same extent in rats aged between 4 and 40 weeks. Endogenous serum receptor-reactive somatomedin appeared exclusively in high molecular weight fractions on gel chromatography. In diabetes the decreased somatomedin was due to a fall in this high molecular weight activity, but was not accompanied by a fall in somatomedin binding protein. These results suggest a role for insulin in maintaining serum somatomedin levels.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
R C Baxter, A S Brown, J R Turtle. 1979. Decrease in serum receptor-reactive somatomedin in diabetes.. https://doi.org/10.1055/s-0028-1092711. https://pubmed.health/record/pubmed%3A221310/decrease-in-serum-receptor-reactive-somatomedin-in-diabetes
Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite PubMed Health by Indiciae: BibTeX · RIS.